Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at

StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners began coverage on shares of Aptevo Therapeutics in a research note on Monday, October 9th. They issued a […]

Related Keywords

United States , , Citadel Advisors , York Mellon Corp , Virtu Financial , Renaissance Technologies , Dimensional Fund Advisors , Aptevo Therapeutics Inc , Alliance Global Partners , Aptevo Therapeutics Company Profile , Aptevo Therapeutics , Free Report , Therapeutics Stock Down , Get Free Report , Fund Advisors , New York Mellon Corp , Therapeutics Inc , Aptevo Therapeutics Daily , Nasdaq Apvo , Apvo , Medical , Initiated Coverage , Stocknews Com ,